We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNXP icon
1251
Tonix Pharmaceuticals
TNXP
$192M
$80K 0.01%
3
SFT
1252
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$79K 0.01%
11,702
+501
+4% +$6.16K
IS
1253
DELISTED
ironSource Ltd.
IS
$78K 0.01%
32,606
-73,050
-69% -$245K
PSFE icon
1254
Paysafe
PSFE
$375M
$77K 0.01%
+3,297
New +$106K
CRMD icon
1255
CorMedix
CRMD
$584M
$75K 0.01%
18,549
-29,473
-61% -$110K
SLQT icon
1256
SelectQuote
SLQT
$121M
$75K 0.01%
30,208
-5,466
-15% -$14K
AXU
1257
DELISTED
Alexco Resource Corp
AXU
$74K 0.01%
184,606
-144,546
-44% -$140K
ZVRA icon
1258
Zevra Therapeutics
ZVRA
$686M
$73K 0.01%
16,428
-67,524
-80% -$308K
TIL icon
1259
Instil Bio
TIL
$50.3M
$72K 0.01%
+775
New +$110K
GGB icon
1260
Gerdau
GGB
$9.7B
$70K 0.01%
+20,553
New +$91.4K
ZETA icon
1261
Zeta Global
ZETA
$6.69B
$70K 0.01%
15,395
+2,150
+16% +$18.9K
XERS icon
1262
Xeris Biopharma Holdings
XERS
$1.45B
$69K 0.01%
44,636
-72,671
-62% -$153K
INO icon
1263
Inovio Pharmaceuticals
INO
$69M
$67K 0.01%
3,230
-4,857
-60% -$137K
CKPT
1264
DELISTED
Checkpoint Therapeutics
CKPT
$65K 0.01%
+6,340
New +$83K
PRTK
1265
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$65K 0.01%
33,571
-45,877
-58% -$100K
APRN
1266
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$63K 0.01%
+1,432
New +$58.3K
BTRS
1267
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$63K 0.01%
12,709
-8,974
-41% -$51.6K
CTOS icon
1268
Custom Truck One Source
CTOS
$2.37B
$62K 0.01%
+11,152
New +$71.1K
XOS icon
1269
Xos
XOS
$37.7M
$62K 0.01%
+1,119
New +$89.4K
ITRM
1270
DELISTED
Iterum Therapeutics
ITRM
$61K 0.01%
+20,312
New +$76K
GENI icon
1271
Genius Sports
GENI
$2.11B
$60K 0.01%
26,473
-99,731
-79% -$336K
GHG
1272
GreenTree Hospitality
GHG
$113M
$58K 0.01%
+13,966
New +$58.3K
ADAM
1273
Adamas Trust
ADAM
$883M
$58K 0.01%
+5,224
New +$64K
ZY
1274
DELISTED
Zymergen Inc. Common Stock
ZY
$58K 0.01%
+47,264
New +$79.2K
BEST
1275
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$56K 0.01%
+11,823
New +$83K

Similar funds

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.